| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner | Director +1 more
20 companies
Perceptive Advisors LLC is a 10% Owner at FOLD with holdings across 20 companies. Recent SEC Form 4 filings include 11 buys and 0 sells.
Estimated insider holdings value: $1178.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 8, 2022 | ALDX Aldeyra Therapeutics, Inc. | 10% Owner | Buy | 97,000 | $7.24 | $702,280.00 | +0.9% | -26.1% | +3.3% | |
| Aug 5, 2022 | ALDX Aldeyra Therapeutics, Inc. | 10% Owner | Buy | 141,000 | $6.95 | $979,950.00 | +1.3% | -20.2% | +16.0% | |
| Aug 4, 2022 | ALDX Aldeyra Therapeutics, Inc. | 10% Owner | Buy | 95,100 | $6.17 | $586,767.00 | +0.9% | -13.3% | +28.7% | |
| Aug 3, 2022 | ALDX Aldeyra Therapeutics, Inc. | 10% Owner | Buy | 100,000 | $5.84 | $584,000.00 | +0.9% | -4.0% | +36.6% | |
| Aug 2, 2022 | ALDX Aldeyra Therapeutics, Inc. | 10% Owner | Buy | 412,406 | $5.59 | $2,305,349.54 | +4.0% | -3.2% | +41.3% | |
| Aug 1, 2022 | ALDX Aldeyra Therapeutics, Inc. | 10% Owner | Buy | 144,185 | $5.05 | $728,134.25 | +1.4% | +7.3% | +57.2% | |
| Jul 29, 2022 | ALDX Aldeyra Therapeutics, Inc. | 10% Owner | Buy | 222,123 | $5.03 | $1,117,278.69 | +2.2% | +9.9% | +58.1% | |
| Jul 28, 2022 | ALDX Aldeyra Therapeutics, Inc. | 10% Owner | Buy | 119,392 | $5.00 | $596,960.00 | +1.2% | +13.2% | +59.4% | |
| Jul 5, 2022 | VRCA Verrica Pharmaceuticals Inc. | 10% Owner | Buy | 1,428,571 | $2.10 | $2,999,999.10 | +39.6% | +19.6% | +136.8% | |
| Jun 30, 2022 | Director, 10% Owner | Buy | 1,371,362 | $2.99 | $4,100,372.38 | +19.3% | - | - |